(Q41479092)

1 October 2017

T cell receptor antagonist peptides are highly effective inhibitors of experimental allergic encephalomyelitis (English)

1 reference

1 October 2017

6

Sette A

1 reference

1 October 2017

Franco A

1

1 reference

1 October 2017

Southwood S

2

1 reference

1 October 2017

Arrhenius T

3

1 reference

1 October 2017

Kuchroo VK

4

1 reference

1 October 2017

Grey HM

5

1 reference

1 October 2017

Ishioka GY

7

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1994

1 reference

European Journal of Immunology

1 October 2017

1 reference

1 October 2017

24

1 reference

1 October 2017

4

1 reference

1 October 2017

940-946

1 reference

Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells

1 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Selective immunosuppression.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Identifying strategies for immune intervention

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

T cell tolerance studied at the level of antigenic determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Immunological activity of covalently linked T-cell epitopes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Amelioration of Autoimmune Encephalomyelitis by Myelin Basic Protein Synthetic Peptide-Induced Anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Molecular components of T-cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240424

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240424

1 reference

1 October 2017

1 reference